Crossmark

BRAIN-Diabetes: a randomised trial to test the feasibility of an adapted FINGER multidomain intervention in adults with type 2 diabetes living in rural border regions of Ireland

Crossref DOI link: https://doi.org/10.1007/s10433-025-00862-0

Published Online: 2025-06-24

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McEvoy, Claire T.

McCarthy, Geraldine

Townsend, Rebecca F.

Dolan, Catherine

Regan-Moriarty, Joanne

Cardwell, Christopher

McGuinness, Bernadette

Kennelly, Seán P.

Kelly, Jim

McHugh, Catherine

Kee, Frank

Bartlett, John

Bradshaw, Caroline

Reynolds, Orla

Mortland, Valerie

O’Neill, Christina

McLoughlin, Ingrid

McCaffrey, Noel

Heffernan, Margaret

Nolan, Cabrini

Passmore, Peter A.
Funding

Funding for this research was provided by:

INTERREG VA (CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018, CHI/5431/2018)
License Information

Text and Data Mining valid from 2025-06-24

Version of Record valid from 2025-06-24
More Information

Article History

Accepted: 14 May 2025

First Online: 24 June 2025

Declarations

:

: Ethical approval for BRAIN-Diabetes was received from the Office for Research Ethics Committees Northern Ireland (REC ref 20/NI/0051) and Sligo University Hospital Research Ethics Committee (775). The study protocol was registered on ClinicalTrials.gov (NCT05304975). Written informed consent was obtained from participants prior to enrolment.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below